Get started
Author

Timothy P. LaBranche

Observed names: T. LaBranche, T. P. LaBRANCHE, T.P. LaBranche, Tim LaBranche, Timothy LaBranche, Timothy P LaBranche, Timothy P. Labranche
Observed institutions: University of Georgia, Pfizer (United States), Washington University in St. Louis, Virginia–Maryland College of Veterinary Medicine, Heska (United States), Blueprint Medicines (United States), Virginia Tech
ORCID: 0000-0003-4715-638X
Observed ORCID: 0000-0003-4715-638X
OpenAlex ID: A5075441975
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
2011 · Kamran Ghoreschi, Michael I Jesson, et al. · The Journal of Immunology · 645
PDF
A precision therapy against cancers driven by KIT/PDGFRA mutations
2017 · Erica K. Evans, Alexandra K. Gardino, et al. · Science Translational Medicine · 207
Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia
2016 · Joseph F. Nabhan, Kristy M. Wood, et al. · Scientific Reports · 140
PDF
JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production
2012 · Timothy P. LaBranche, Michael I. Jesson, et al. · Arthritis & Rheumatism · 139
Th17 cells can provide B cell help in autoantibody induced arthritis
2010 · Cynthia L. Hickman-Brecks, Jennifer L. Racz, et al. · Journal of Autoimmunity · 71
Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model
2016 · Timothy P LaBranche, Alison M Bendele, et al. · Annals of the Rheumatic Diseases · 64
PDF
Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis
2010 · Jeffrey D Peterson, Timothy P LaBranche, et al. · Arthritis Research & Therapy · 62
PDF
Efficacy of fenbendazole in the treatment of experimental Giardia infection in dogs
1998 · Anne M. Zajac, Timothy P. LaBranche, et al. · American Journal of Veterinary Research · 52
PDF
Enhanced GITR / GITRL interactions augment IL ‐27 expression and induce IL ‐10‐producing Tr‐1 like cells
2012 · Yijun Carrier, Matthew J. Whitters, et al. · European Journal of Immunology · 46
Characterization of the KRN Cell Transfer Model of Rheumatoid Arthritis (KRN-CTM), a Chronic Yet Synchronized Version of the K/BxN Mouse
2010 · Timothy P. LaBranche, Cynthia L. Hickman-Brecks, et al. · American Journal Of Pathology · 35
PDF
In vivo imaging implicates CCR2+ monocytes as regulators of neutrophil recruitment during arthritis
2012 · Baomei Wang, Bernd H. Zinselmeyer, et al. · Cellular Immunology · 34
PDF
Platelet‐activating factor increases pH(i)in bovine neutrophils through the PI3K–ERK1/2 pathway
2004 · María A Hidalgo, Flavio Ojeda, et al. · British Journal of Pharmacology · 29
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva
2024 · Alison J. Davis, Natasja Brooijmans, et al. · Science Translational Medicine · 21
Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model
2013 · Joanne Brodfuehrer, Andrew Rankin, et al. · Pharmaceutical Research · 20
14-Deoxyandrographolide as a Platelet Activating Factor Antagonist in Bovine Neutrophils
2005 · Rafael A. Burgos, María A. Hidalgo, et al. · Planta Medica · 20
Effect of 14‐deoxyandrographolide on calcium‐mediated rat uterine smooth muscle contractility
2003 · Rafael A. Burgos, Mario Loyola, et al. · Phytotherapy Research · 18
Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma
2022 · Stefanie S. Schalm, Erin O’Hearn, et al. · Gastro Hep Advances · 13
PDF
Characterization of bovine neutrophil β2‐adrenergic receptor function
2010 · T. P. LaBRANCHE, M. F. EHRICH, et al. · Journal of Veterinary Pharmacology and Therapeutics · 9
Abstract B151: BLU-667 is a potent and highly selective RET inhibitor being developed for RET-driven cancers
2018 · Rami Rahal, Michelle Maynard, et al. · Molecular Cancer Therapeutics · 8
Abstract 1279: Development of a selective CDK2-E inhibitor in CCNE driven cancers
2021 · Yoon J. Choi, Steve Wenglowsky, et al. · Cancer Research · 7
Renal and Hematologic Comparative Effects of Dissociated Agonist of the Glucocorticoid Receptor and Prednisone in Dogs With and Without Food Restriction
2018 · Zaher A. Radi, W. Mark Vogel, et al. · International Journal of Toxicology · 7
PDF
Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat Model
2020 · Timothy P. LaBranche, Anna K. Kopec, et al. · Toxicologic Pathology · 5
Evaluation of PRKACA as a Therapeutic Target for Fibrolamellar Carcinoma
2022 · Stefanie S. Schalm, Erin O’Hearn, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
PDF
Inside-Out
2013 · M. J. Oglesbee, T. LaBranche · Veterinary Pathology · 4
Abstract 1717: MAP4K1 inhibition enhances immune cell activation and anti-tumor immunity in preclinical tumor models
2021 · Kerrie Faia, Alberto Toso, et al. · Cancer Research · 3
Works count: 31
Citation count: 1,664
H-index: 16
I10-index: 17
Year
Topic
Type